HDT BIO CORP
SEATTLE, WA, 98109
Prime contracting experience
4 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | COVID-19. TO DEVELOP AND PROGRESS HDT-301, A REPLICON RNA ENCODING SARS-COV-2 SPIKE PROTEIN BOUND TO LIPID INORGANIC NANOPARTICLE (LION) FORMULATION TO PROTECT AGAINST COVID-19, THROUGH A PHASE I CLINICAL TRIAL. | — | $10,970,058 | Oct 26, 2023 | Sep 1, 2020 – Jun 30, 2024 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | HDT BIO CORP - AOI #21 VACCINE ON DEMAND: R&D USE OF LION-REPRNA IN RAPID RESPONSE VACCINE DEVELOPMENT | — | $749,000 | Sep 21, 2023 | Sep 22, 2023 – Sep 30, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | ADAPTABLE RNA-BASED ANTIBODY PLATFORM FOR PROTECTION AGAINST CONTEMPORARY/EMERGING HUMAN ENTEROVIRUSES | — | $1,499,422 | Jul 1, 2022 | Jul 1, 2022 – Jun 30, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | RATIONAL DEVELOPMENT OF A COMBINATION NANOPARTICLE ADJUVANT FOR INFLUENZA. | — | $599,629 | Nov 18, 2021 | Sep 1, 2019 – Nov 30, 2021 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | POTENCY ASSAY DEVELOPMENT PO 234322 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541690 Parent award performance state: MO Parent award description: CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT View parent award on USAspending | 75N91023D00010USAspending | $291,987 | Jun 29, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | TECHNOLOGY TRANSFER, ANALYTICAL METHODS, PRODUCTION, TESTING, AND MASTER CELL BANK. PO 232291 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541690 Parent award performance state: MO Parent award description: MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE View parent award on USAspending | 75N91023D00010USAspending | $2,922,394 | Oct 22, 2025 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.